+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2014-02-06Number of Pages: 78

Organ Preservation Solutions Market (By Solutions - Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solution and Others, and By Preservation Techniques- Hypothermic Perfusion Preservation, Static Cold Storage and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Global Organ Preservation Solutions Market: Snapshot

The global market for organ preservation solutions is expected to witness substantial growth throughout the forecast period. The rising number of opportunities through strategic partnership with research organizations and medical institutions is projected to help the prominent players in expanding their consumer base. In addition, the growing focus on advanced in the medical sector is likely to contribute widely towards the development of the overall market in the next few years. However, the limited medical reimbursements for organ transplantation and donation are estimated to curb the growth of the overall market in the next few years.

According to the study, in 2012, the global market for organ preservation solutions was worth US$0.06 bn and is estimated to reach a value of US$0.20 bn by the end of 2019. Thanks to the rising awareness among consumers regarding the benefits of donation of organs, the global market is predicted to register a progressive 16.50% CAGR between 2013 and 2019.

Growing Awareness Concerning Organ Donation to Accelerate Growth

The rising NGO and government initiatives to encourage organ donation and the increasing number of solid-organ transplantation procedures are some of the vital factors expected to fuel the growth of the global organ preservation solutions market in the near future. Additionally, the tremendously rising cases of organ failures worldwide and technological developments in this field are predicted to supplement the growth of the market. However, the high cost of organ transplantation is estimated to restrict the growth of the market in the near future.

On the basis of solution, the global organ preservation solutions market has been divided into viaspan, RENOGRAF, hypoThermosol, custodiol HTK, PERFADEX, lifor human bioSystems, and siRNA Transplant Solutions. Furthermore, the key segments of the global organ preservation solutions market in terms of preservation are static cold storage, hypothermic perfusion preservation, and others. Innovations in the preservation methods is expected to offer promising opportunities for the leading market players.

Rising Number of Organ Donors to Supplement Growth of Europe Organ Preservation Solutions Market

From a geographical perspective, the global organ preservation solutions market can be divided into Europe, Asia Pacific, North America, and the Rest of the World. In 2012, Europe led the global market and is expected to remain in the leading position in the next few years. Thanks to the technological advancements in this field, the Europe market for organ preservation solutions is projected to register a progressive growth rate in the near future. In addition, the substantial contribution from Spain is expected to accelerate the growth of the market in the near future.

Furthermore, the rising number of organ donors and the policy of being an organ donor after death are some of the factors estimated to contribute towards the growth of the Europe market. The increasing awareness regarding the need for organ donation among the people and the rising number of initiatives taken by government to encourage organ donation are some of the other factors projected to fuel the growth of the market in the near future.

Some of the leading players operating in the organ preservation solutions market across the globe are Teva Pharmaceutical Industries Ltd., Claris Lifesciences Limited, BioTime, Inc., XVIVO Perfusion AB, Dr. Franz Köhler Chemie GmbH, Lifeline Scientific, CryoLife, Inc., ToleroTech, Inc., Bristol-Myers Squibb, BioLife Solutions, Inc., and 21st Century Medicine. The rising number of players in the market are projected to strengthen the competitive scenario of the global organ preservation solutions market in the next few years.

 

Chapter 1 Introduction

1.1 Report Description

1.2 Market Segmentation

1.3 Research Methodology

 

Chapter 2 Executive Summary

 

Chapter 3 Market Overview

3.1 Introduction

3.2 Market Drivers

      3.2.1 Aging global population

              3.2.1.1 Global rate of aging population

      3.2.2 Technological advancements

      3.2.3 Increasing reimbursement scenario

      3.2.4 Increase in per capita healthcare expenditure

3.3 Market Restraints

      3.3.1 Lack of organ donors

              3.3.1.1 Widening Gap Between Patients Receiving Organ Transplants and Number of Donors in the U.S. (1998 - 2010)

      3.3.2 High cost of procedure

3.4 Market Opportunities

      3.4.1 Collaboration with research-oriented organizations and medical institutes to ensure retention of customer base

3.5 Porter’s Five Force Analysis for the Global Organ Preservation Solutions Market

      3.5.1 Bargaining power of suppliers

      3.5.2 Bargaining power of buyers

      3.5.3 Threat of substitutes

      3.5.4 Threat of new entrants

      3.5.5 Competitive rivalry

3.6 Market Attractiveness Analysis: Global Organ Preservation Solutions Market, by Geography

 

Chapter 4 Global Organ Preservation Solutions Market, By Solution, 2011 – 2019 (USD Million)

4.1 Overview

      4.1.1 Global Organ Preservation Solutions Market Revenue, by Solution Type, 2011 - 2019 (USD Million)

      4.1.2 Comparative Analysis: Global Organ Preservation Solutions Market, by Solution Type, 2012 & 2019 (Value %)

4.2 Viaspan

      4.2.1 Global Viaspan Market Revenue, 2011 - 2019 (USD Million)

4.3 Custodiol HTK – (Histidine-Tryptophan-Ketoglutarate) Solution

      4.3.1 Global Custodiol Market Revenue, 2011 - 2019 (USD Million)

4.4 Renograf

      4.4.1 Global Renograf Market Revenue, 2011 - 2019 (USD Million)

4.5 Hypothermosol

      4.5.1 Global Hypothermosol Market Revenue, 2011 - 2019 (USD Million)

4.6 Perfadex

      4.6.1 Global Perfadex Market Revenue, 2011 - 2019 (USD Million)

4.7 Lifor

      4.7.1 Global Lifor Market Revenue, 2011 - 2019 (USD Million)

4.8 Human bioSystem (HBS) Solution

      4.8.1 Global HBS Solution Market Revenue, 2011 - 2019 (USD Million)

4.9 siRNA Transplant Solution

      4.9.1 Global siRNA Transplant Solution Market Revenue, 2011 - 2019 (USD Million)

4.10 Others

      4.10.1 Global Other Solutions Market Revenue, 2011 - 2019 (USD Million)

 

Chapter 5 Global Organ Preservation Solutions Market, By Preservation Technique, 2011 – 2019 (USD Million)

5.1 Overview

      5.1.1 Global Organ Preservation Solutions Market Revenue, by Preservation Technique, 2011 - 2019 (USD Million)

      5.1.2 Comparative Analysis: Global Organ Preservation Solutions Market, by Preservation Technique, 2012 & 2019 (Value %)

5.2 Hypothermic Perfusion Preservation (HPP)

      5.2.1 Global Hypothermic Perfusion Preservation Market Revenue, 2011 - 2019 (USD Million)

5.3 Static Cold Storage (SCS)

      5.3.1 Global Static Cold Storage Market Revenue, 2011 - 2019 (USD Million)

5.4 Others

      5.4.1 Global Other Preservation Techniques Market Revenue, 2011 - 2019 (USD Million)

 

Chapter 6 Global Organ Preservation Solutions Market, By Geography, 2011 – 2019 (USD Million)

6.1 Overview

      6.1.1 Global Organ Preservation Solutions Market Revenue, by Geography, 2011 - 2019 (USD Million)

      6.1.2 Comparative Analysis: Global Organ Preservation Solutions Market, by Geography, 2012 & 2019 (Value %)

6.2 North America

      6.2.1 North America Organ Preservation Solutions Market Revenue, 2011 - 2019 (USD Million)

6.3 Europe

      6.3.1 Europe Deceased Donation Rate (Per Million of Population), by Country, 2011

      6.3.2 Europe Organ Donation and Transplantation Data, 2011

      6.3.3 Donation and Transplantation Number Per European Country, 2011

      6.3.4 Europe Organ Preservation Solutions Market Revenue, 2011 - 2019 (USD Million)

6.4 Asia Pacific

      6.4.1 Organ Donation and Transplantation Data for Japan (2009 - 2013)

      6.4.2 Asia Pacific Organ Preservation Solutions Market Revenue, 2011 - 2019 (USD Million)

6.5 Rest of the World (RoW)

      6.5.1 RoW Organ Preservation Solutions Market Revenue, 2011 - 2019 (USD Million)

 

Chapter 7 Competitive Landscape

7.1 Market Share by Key Players, 2012 (%)

 

Chapter 8 Recommendations

8.1 Long term contracts with healthcare service providers

8.2 Broadening of distribution network

8.3 Product innovation

 

Chapter 9 Company Profiles

9.1 21st Century Medicine

      9.1.1 Company Overview

      9.1.2 Product Portfolio

9.2 BioLife Solutions, Inc.

      9.2.1 Company Overview

      9.2.2 Financial Overview

      9.2.3 Product Portfolio

      9.2.4 Business Strategies

      9.2.5 Recent Developments

9.3 BioTime, Inc.

      9.3.1 Company Overview

      9.3.2 Financial Overview

      9.3.3 Product Portfolio

      9.3.4 Business Strategies

      9.3.5 Recent Developments

9.4 Bristol-Myers Squibb

      9.4.1 Company Overview

      9.4.2 Financial Overview

      9.4.3 Product Portfolio

      9.4.4 Business Strategies

      9.4.5 Recent Developments

9.5 Claris Lifesciences Limited

      9.5.1 Company Overview

      9.5.2 Financial Overview

      9.5.3 Product Portfolio

      9.5.4 Business Strategies

      9.5.5 Recent Developments

9.6 CryoLife, Inc.

      9.6.1 Company Overview

      9.6.2 Financial Overview

      9.6.3 Product Portfolio

      9.6.4 Business Strategies

      9.6.5 Recent Developments

9.7 Dr. Franz Köhler Chemie GmbH

      9.7.1 Company Overview

      9.7.2 Product Portfolio

      9.7.3 Business Strategies

9.8 Lifeline Scientific

      9.8.1 Company Profile

      9.8.2 Financial Overview

      9.8.3 Product Portfolio

      9.8.4 Business Strategies

      9.8.5 Recent Developments

9.9 Teva Pharmaceutical Industries Ltd.

      9.9.1 Company Profile

      9.9.2 Financial Overview

      9.9.3 Product Portfolio

      9.9.4 Business Strategies

      9.9.5 Recent Developments

9.10 ToleroTech, Inc.

      9.10.1 Company Profile

      9.10.2 Product Portfolio

      9.10.3 Business Strategies

9.11 XVIVO Perfusion AB

      9.11.1 Company Overview

      9.11.2 Financial Overview

      9.11.3 Product Portfolio

      9.11.4 Business Strategies

List of Figures

 

FIG. 1 Organ Preservation Solutions Market Segmentation

FIG. 2 Global Organ Preservation Solutions Market, by Solution, 2012 (USD Million)

FIG. 3 Global Organ Preservation Solutions Market, by Preservation Technique, 2012 (USD Million)

FIG. 4 Global Rate of Aging Population

FIG. 5 Gap Between Organ Transplant and Donors in the U.S. (1998 - 2010)

FIG. 6 Porter’s Five Force Analysis: Global Organ Preservation Solutions Market

FIG. 7 Market Attractiveness Analysis: Global Organ Preservation Solutions Market, by Geography

FIG. 8 Comparative Analysis: Global Organ Preservation Solutions Market, by Solution Type, 2012 & 2019 (Value %)

FIG. 9 Global Viaspan Market Revenue, 2011 – 2019 (USD Million)

FIG. 10 Global Custodiol Market Revenue, 2011 – 2019 (USD Million)

FIG. 11 Global Renograf Market Revenue, 2011 – 2019 (USD Million)

FIG. 12 Global Hypothermosol Market Revenue, 2011 – 2019 (USD Million)

FIG. 13 Global Perfadex Market Revenue, 2011 – 2019 (USD Million)

FIG. 14 Global Lifor Market Revenue, 2011 – 2019 (USD Million)

FIG. 15 Global HBS Solution Market Revenue, 2011 – 2019 (USD Million)

FIG. 16 Global siRNA Transplant Solution Market Revenue, 2011 – 2019 (USD Million)

FIG. 17 Global Other Solutions Market Revenue, 2011 – 2019 (USD Million)

FIG. 18 Comparative Analysis: Global Organ Preservation Solution Market, by Preservation Technique, 2012 & 2019 (Value %)

FIG. 19 Global Hypothermic Perfusion Preservation Market Revenue, 2011 – 2019 (USD Million)

FIG. 20 Global Static Cold Storage Market Revenue, 2011 – 2019 (USD Million)

FIG. 21 Global Other Preservation Techniques Market Revenue, 2011 – 2019 (USD Million)

FIG. 22 Comparative Analysis: Global Organ Preservation Solution Market, by Geography, 2012 & 2019 (Value %)

FIG. 23 North America Organ Preservation Solutions Market Revenue, 2011 – 2019 (USD Million)

FIG. 24 Europe Organ Preservation Solutions Market Revenue, 2011 – 2019 (USD Million)

FIG. 25 Asia Pacific Organ Preservation Solutions Market Revenue, 2011 – 2019 (USD Million)

FIG. 26 RoW Organ Preservation Solutions Market Revenue, 2011 – 2019 (USD Million)

FIG. 27 Market Share by Key Players, 2012 (%)

FIG. 28 Annual Revenue: BioLife Solutions, Inc., 2010 – 2012 (USD Million)

FIG. 29 Annual Revenue: BioTime Inc., 2010 – 2012 (USD Million)

FIG. 30 Annual Revenue: Bristol-Myers Squibb, 2010 – 2012 (USD Million)

FIG. 31 Annual Sales: Claris Lifesciences Ltd., 2010 – 2012 (USD Million)

FIG. 32 Annual Revenue: CryoLife, Inc., 2010 – 2012 (USD Million)

FIG. 33 Annual Revenue: Lifeline Scientific, 2010 – 2012 (USD Million)

FIG. 34 Annual Revenue: Teva Pharmaceutical Industries Ltd., 2010 – 2012 (USD Million)

FIG. 35 Annual Sales: XVIVO Perfusion AB, 2010 – 2012 (USD Million)

List of Tables

 

TABLE 1 Market Snapshot: Global Organ Preservation Solutions Market

TABLE 2 Global Organ Preservation Solutions Market Revenue, by Solution, 2011 – 2019 (USD Million)

TABLE 3 Global Organ Preservation Solutions Market Revenue, by Preservation Technique, 2011 – 2019 (USD Million)

TABLE 4 Global Organ Preservation Solutions Market Revenue, by Geography, 2011 – 2019 (USD Million)

TABLE 5 Organ Donation and Transplantation Data for Japan (2009 - 2013)

 

Organ preservation solutions are used to preserve organs before transplantation procedure as these organs in external climate are vulnerable and also become dysfunctional once taken out from the human body. To preserve and maintain organs functionality for their further usage such as transplantation and research, organ preservation solutions are used. Increasing demand for organ transplantation procedures across the globe is expected to drive the growth of organ preservation solutions market. In addition, aging population will also propel the growth of organ preservation solutions market as the risk of organ failure in elderly people increases that augments the demand for organ transplants. Likewise, development of technologically advanced solutions for preserving organs will further accentuate the growth of organ preservation solutions market.

 

This report studies the global organ preservation solutions market based on the various solutions available in the market in which organs are preserved. These solutions include Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solution and others (Ross-Marshall Citrate Solutions, Celsior Solution, Phosphate-Buffered Sucrose Solution, ET-Kyoto, TranSend, HetaFreeze, MaPersol and CryoStor). The market for these solutions has been extensively analyzed based on number of organ transplant, efficiency and application area. The market size and forecast in terms of USD million for each product type has been provided for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2013 to 2019 for each segment.

 

Based on the type of preservation techniques used to preserve organs, market has been segmented as hypothermic perfusion preservation (HPP), static cold storage (SCS) and others (that include normothermic preservation and oxygen insufflation techniques). The market for these technologies has been extensively analyzed based on number of organ transplant, compatibility with solution and organs, and cost. The market size and forecast in terms of USD million for each product type has been provided for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2013 to 2019 for each segment.

 

Geographically, the report studies the global market with respect to four main regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecasts in terms of revenue (USD million) for the period 2011 to 2019, considering 2012 as the base year, have been provided for this segment. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2013 to 2019 for each segment.

 

The market overview section of the report discusses the market dynamics that include drivers, restraints and opportunities influencing the market. In addition, major events have also been discussed in the section that have boosted the growth of the market and expected to further propel the growth during the forecast period. Also, this section covers market attractiveness analysis (by geography) for the year 2012 and Porter’s five forces analysis for the global ultrasound devices market. Market share (%) by revenue for the major players operating in this market has also been provided for the year 2012 in the competitive landscape section, followed by a list of recommendations for the existing and new players. In addition, the report also profiled key players of the market on various parameters such as business overview, financial overview, product portfolio, business strategies and recent developments of the respective company. Some of the prominent players in the organ preservation solutions market that have been profiled in this report include Dr. Franz Köhler Chemie GmbH, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb, BioLife Solutions, Inc., XVIVO Perfusion AB and ToleroTech, Inc.

 

The global organ preservation solutions market has been segmented as below:

 

Organ Preservation Solutions Market, by Solution 

  • Viaspan
  • Custodiol HTK (Histidine-Tryptophan-Ketoglutarate) Solution
  • RENOGRA
  • HypoThermosol
  • PERFADEX
  • Lifor
  • Human BioSystems (HBS) Solution
  • siRNA Transplant Solutions
  • Others

Organ Preservation Solutions Market, by Preservation Technique

  • Hypothermic Perfusion Preservation (HPP)
  • Static Cold Storage (SCS)
  • Others 

Organ Preservation Solutions Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)


 
 
Back To Top